Benchling

Anthropic Launches Claude for Life Sciences with New Connectors, Agent Skills, and Benchmark Improvements

Anthropic has announced a dedicated life sciences offering for Claude, targeting the full drug discovery and commercialization pipeline rather than individual tasks. Claude Sonnet 4.5 achieves 0.83 on the Protocol QA benchmark (above the human baseline of 0.79) and shows improvements on BioRench bioinformatics evaluations. The launch includes new connectors to platforms such as Benchling, BioRender, PubMed, Synapse.org, and 10x Genomics, plus a new Agent Skills framework starting with a single-cell RNA QC skill. Anthropic is partnering with major consultancies (Deloitte, Accenture, KPMG, PwC) and cloud providers (AWS, Google Cloud), with Sanofi cited as a flagship enterprise customer.